Polypharmacy
SubstackA psychiatrist's Substack examining the evidence base and marketing practices around transcranial magnetic stimulation for depression, including the claim that TMS trial data are weaker than commonly presented. It also covers the speed of antipsychotic action and the pharmacology behind it, drawing on the clinical literature.